India  

U.S. doctors call for remdesivir data to guide coronavirus treatment

Reuters India Friday, 22 May 2020 ()
U.S. doctors and others in the scientific community are calling for the release of data that convinced health regulators to authorize emergency use of Gilead Sciences Inc's antiviral drug remdesivir to treat COVID-19, so they can direct limited supplies on the right patients.
0
shares
ShareTweetSavePostSend
 

Related videos from verified sources

How much will COVID-19 treatment Remdesivir actually cost? [Video]

How much will COVID-19 treatment Remdesivir actually cost?

The drug Remdesivir has been hailed as a potentially life-saving treatment to fight the novel coronvirus. But how much will it cost as more hospitals and doctors use it?

Credit: NBC 26 Wisconsin     Duration: 02:28Published
Stock Gains Accelerate as Remdesivir Treatment Approved in Japan [Video]

Stock Gains Accelerate as Remdesivir Treatment Approved in Japan

Positive signals from economic data and earnings paired with news on Gilead's remdesivir treatment helped to bolster stocks.

Credit: The Street     Duration: 01:12Published

You Might Like


Tweets about this